Note: Ingredients listed on restricted chemical lists
EC/CAS
202-222-5/93-14-1
Name of the chemical
Guaifenesin (INN)
Concentration
61,3
EC/CAS
232-674-9/9004-34-6
Name of the chemical
cellulose
Concentration
Acute Tox. 4;H302 28
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
- 4,8
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
Acute Tox. 4;H302 0,9
General Information
Revision date
2021-02-03
Product name
Primatene Tablets
Product Synonyms
WH-0185-0088
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
EU Classification
Regulation (EC) No 1272/2008 as amended
Health hazards
Acute toxicity, oral Category 4 H302 - Harmful if swallowed. Hazard summary Not available.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
EPHEDRINE HYDROCHLORIDE, GUAIPHENESIN
Signal word
Warning
Hazard statements
H302 Harmful if swallowed.
Prevention
P264 Wash thoroughly after handling. P270 Do not eat, drink or smoke when using this product.
Response
P301 + P312 IF SWALLOWED: Call a POISON CENTRE/doctor/ if you feel unwell. P330 Rinse mouth.
Storage
Not available.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental label elements
30 % of the mixture consists of component(s) of unknown acute oral toxicity. 96,1 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 91,3 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
None known.
